Biopharmaceuticals Market Predicted to Surge to USD 857.29 Billion by 2031 The global biopharmaceuticals market, valued at USD 461.45 billion in 2023, is projected to grow at a robust CAGR of 8.09%, reaching USD 857.29 billion by 2031. This significant growth is driven by the rising prevalence of chronic diseases, advancements in biotechnology, and an expanding geriatric population. As biotechnology innovations continue to evolve, the market is expected to see an influx of advanced therapeutic solutions. The Biopharmaceuticals Market is experiencing rapid growth driven by advancements in biotechnology and increasing demand for targeted therapies. These drugs, derived from biological sources, are used to treat a range of chronic diseases, including cancer, autoimmune disorders, and infectious diseases. Factors such as rising healthcare expenditures, growing prevalence of chronic conditions, and expanding biopharmaceutical research are fueling market expansion. Additionally, innovations in gene therapies, monoclonal antibodies, and biosimilars are contributing to the dynamic growth of this market. The sector is expected to continue expanding significantly in the coming years. Download Full PDF Sample Copy of Research Report @ https://www.verifiedmarketresearch.com/download-sample/?rid=144437